Literature DB >> 15750596

The chemokine receptor D6 limits the inflammatory response in vivo.

Thomas Jamieson1, Donald N Cook, Robert J B Nibbs, Antal Rot, Colin Nixon, Pauline McLean, Antonio Alcami, Sergio A Lira, Maria Wiekowski, Gerard J Graham.   

Abstract

How the inflammatory response is initiated has been well defined but relatively little is known about how such responses are resolved. Here we show that the D6 chemokine receptor is involved in the post-inflammatory clearance of beta-chemokines from cutaneous sites. After induction of inflammation by phorbol esters, wild-type mice showed a transient inflammatory response. However, in D6-deficient mice, an excess concentration of residual chemokines caused a notable inflammatory pathology with similarities to human psoriasis. These results suggest that D6 is involved in the resolution of the cutaneous inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750596     DOI: 10.1038/ni1182

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  111 in total

1.  Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation.

Authors:  Simon Schwager; Silvana Renner; Teresa Hemmerle; Sinem Karaman; Steven T Proulx; Roman Fetz; Alexandra Michaela Golding-Ochsenbein; Philipp Probst; Cornelia Halin; Dario Neri; Michael Detmar
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

3.  Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Authors:  Ziv Shulman; Shmuel J Cohen; Ben Roediger; Vyacheslav Kalchenko; Rohit Jain; Valentin Grabovsky; Eugenia Klein; Vera Shinder; Liat Stoler-Barak; Sara W Feigelson; Tsipi Meshel; Susanna M Nurmi; Itamar Goldstein; Olivier Hartley; Carl G Gahmberg; Amos Etzioni; Wolfgang Weninger; Adit Ben-Baruch; Ronen Alon
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

4.  Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis.

Authors:  Xiao-Mei Yang; Hai-Xiong Han; Fei Sui; Yu-Min Dai; Ming Chen; Jian-Guo Geng
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

Review 5.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

6.  Chemokine decoy receptor D6 in inflammatory bowel disease (IBD) and IBD-associated colon cancer.

Authors:  Colm B Collins; Eoin N McNamee; Joshua D Wermers; Matthew D P Lebsack; Jesús Rivera-Nieves
Journal:  Gut       Date:  2010-02       Impact factor: 23.059

7.  Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.

Authors:  Ravindra Rajakariar; Justine Newson; Edwin K Jackson; Precilla Sawmynaden; Andrew Smith; Farooq Rahman; Muhammad M Yaqoob; Derek W Gilroy
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.

Authors:  Jennifer N Lilla; Ravi V Joshi; Charles S Craik; Zena Werb
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

10.  Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Authors:  Michael J Flister; Andrew Wilber; Kelly L Hall; Caname Iwata; Kohei Miyazono; Riccardo E Nisato; Michael S Pepper; David C Zawieja; Sophia Ran
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.